Lomitapide cost?

Current Cost of Lomitapide

Lomitapide is a prescription medication used to treat a genetic disorder called Homozygous Familial Hypercholesterolemia (HoFH), which leads to extremely high levels of low-density lipoprotein (LDL) cholesterol in the blood. The cost of lomitapide can vary depending on the dosage, treatment duration, and insurance coverage.

Generic Availability

As of the latest data available [1], lomitapide is not yet available in a generic or biosimilar form. Therefore, patients typically rely on the branded version, Juxtapid or Lojuxta, depending on their location. The cost of these medications can be high, which makes access difficult for many patients.

Manufacturer Prices

The manufacturer, Aegerion Pharmaceuticals (now part of Chiesi Farmaceutici [2]), previously offered a patient access program, known as the Lomitapide Access Program (LAP). However, since the change in ownership, the access program might be different. We could not confirm the manufacturer's prices directly.

Insurance Coverage and Discounts

Insurance companies may cover a portion of the lomitapide costs, depending on the individual plan and patient eligibility. Patients should check with their insurance providers to understand the extent of coverage.

Clinical Trials and Emerging Options

Researchers continue to explore alternative treatments for HoFH, including other medications and potential gene therapies. Clinical trials and new developments could potentially lead to more affordable and effective treatments in the future.

References:

[1] DrugPatentWatch.com (latest update available)
[2] Aegerion Pharmaceuticals (now Chiesi Farmaceutici)
[3] Available at: www.aegerion.com

Sources:

1. www.drugpatentwatch.com
2. www.chiesifarmaceutici.com